Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Early Diagnosis Of Chemotherapy-induced Cardiotoxicity By Cardiac MRI.
Riccardo Cau, Pierpaolo Bassareo, V. Cherchi, V. Palmisano, J. S. Suri, M. Porcu, A. Balestrieri, G. Pontone, L. Saba
Published 2020 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Survival rate in cancer patients has improved over the course of the years. In cancer survivors, cardiovascular disease is the second leading cause of mortality and early detection and serial monitoring of cardiotoxicity are key factors towards the improvement of patients' outcomes. This review article will provide an overview of the existing literature regarding the tools that MRI can offer in the early diagnosis of myocardial damage.
This paper references
Assessment of myocardial fibrosis with cardiovascular magnetic resonance.
N. Mewton (2011)
Automated analysis of cardiovascular magnetic resonance myocardial native T1 mapping images using fully convolutional neural networks
A. S. Fahmy (2019)
Relation of strain by feature tracking and clinical outcome in children, adolescents, and young adults with hypertrophic cardiomyopathy.
Brandon M. Smith (2014)
Cardiac MRI for the evaluation of oncologic cardiotoxicity
A. I. Löffler (2018)
Mapping cardiac microstructure of rabbit heart in different mechanical states by high resolution diffusion tensor imaging: A proof-of-principle study
I. Teh (2016)
Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion.
E. Zerhouni (1988)
Advances in parametric mapping with CMR imaging.
M. Salerno (2013)
Early anthracycline cardiotoxicity.
M. Bristow (1978)
Ten principles of good interdisciplinary team work
S. Nancarrow (2013)
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
P. Ponikowski (2016)
Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
S. Nakamori (2018)
Machine learning in cardiovascular magnetic resonance: basic concepts and applications
T. Leiner (2019)
Myocardial strain assessed by feature tracking cardiac magnetic resonance in patients with a variety of cardiovascular diseases – A comparison with echocardiography
K. Pryds (2019)
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines.
T. Neilan (2012)
Tissue Tracking Technology for Assessing Cardiac Mechanics: Principles, Normal Values, and Clinical Applications.
P. Claus (2015)
Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study
Y. J. Hong (2017)
Focal fibrosis and diffuse fibrosis are predictors of reversed left ventricular remodeling in patients with non-ischemic cardiomyopathy.
T. Yingchoncharoen (2016)
Doxorubicin induced heart failure: Phenotype and molecular mechanisms
M. Mitry (2016)
Artificial Intelligence in Cardiology.
K. Johnson (2018)
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Brandon C. Drafts (2013)
Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
Carlos Galán‐Arriola (2019)
Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
E. T. Yeh (2009)
Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
S. Buß (2015)
Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors
J. Jordan (2016)
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
G. D. De Backer (2003)
The present and future of deep learning in radiology.
L. Saba (2019)
Cardiovascular Magnetic Resonance in the Oncology Patient
J. Jordan (2018)
Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender
D. Augustine (2013)
Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks.
A. Fahmy (2018)
Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs
R. Jiji (2012)
Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance.
E. Altiok (2014)
Performance of a deep learning algorithm for the evaluation of CAD-RADS classification with CCTA.
G. Muscogiuri (2019)
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
W. Hundley (2010)
Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis
M. Spieker (2017)
Native myocardial T1 time can predict development of subsequent anthracycline‐induced cardiomyopathy
F. Muehlberg (2018)
Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance
C. Nguyen (2015)
Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping
P. Thavendiranathan (2012)
Feature-tracking myocardial strain in healthy adults- a magnetic resonance study at 3.0 tesla
K. Mangion (2019)
Strain imaging using cardiac magnetic resonance
A. Scatteia (2017)
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
R. Kim (2000)
Pathology of late-onset anthracycline cardiomyopathy.
Bob N Bernaba (2010)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
J. Zamorano (2017)
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer
H. Abdel-Qadir (2017)
DENSE: displacement encoding with stimulated echoes in cardiac functional MRI.
A. Aletras (1999)
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans
A. Flett (2010)
Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
Kaisa Ylänen (2013)
The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
I. Mordi (2015)
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J. Plana (2014)
Deep Learning Techniques for Automatic MRI Cardiac Multi-Structures Segmentation and Diagnosis: Is the Problem Solved?
O. Bernard (2018)
Myocardial tagging with MR imaging: overview of normal and pathologic findings.
M. Jeung (2012)
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
R. G. Schwartz (1987)
Cardio-oncology: A Focus on Cardiotoxicity.
A. Koutsoukis (2018)
Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion
R. Fernández‐Jiménez (2015)
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
D. Mulrooney (2009)
Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling
E. Tham (2013)
Imaging longitudinal cardiac strain on short‐axis images using strain‐encoded MRI
N. Osman (2001)
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.
M. Ewer (2005)
Significance of Late Gadolinium Enhancement in Cardiovascular Magnetic Resonance Imaging (CMR)
M. Voehringer (2007)
Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy.
G. Ong (2018)
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.
G. Curigliano (2012)
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
S. L. Heck (2018)
Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know?
L. Oreto (2012)
T2 quantification for improved detection of myocardial edema
S. Giri (2009)
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
J. Moon (2013)
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.
A. Barac (2015)
Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals.
M. Friedman (1978)
Advanced Imaging Modalities to Monitor for Cardiotoxicity
A. Seraphim (2019)
Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome
E. Schelbert (2017)
Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician
Irving E. Perez (2019)
Comparison of Comorbid Conditions Between Cancer Survivors and Age-Matched Patients Without Cancer
S. Roy (2018)
Chronic Health Conditions in Adult Survivors of Childhood Cancer
K. Oeffinger (2006)
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
N. Fallah-Rad (2008)
Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance
S. Vasu (2013)
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.
F. Grothues (2002)
Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy
M. Lunning (2015)
Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review
P. Haaf (2016)
Interrogation of living myocardium in multiple static deformation states with diffusion tensor and diffusion spectrum imaging
M. Lohezic (2014)
T2-Weighted Cardiac Magnetic Resonance Imaging of Edema in Myocardial Diseases
Y. Amano (2012)
Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
J. Erley (2019)
Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity.
M. Nolan (2016)
The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
Sarah J Parent (2016)
Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: normal values.
R. Taylor (2015)
Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy
M. Jolly (2017)
T1 Mapping: Basic Techniques and Clinical Applications.
A. Taylor (2016)
Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.
T. Neilan (2013)
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
N. Pavo (2015)
Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.
D. Cardinale (2010)
Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.
J. Voigt (2015)
MR imaging of cardiac tumors and masses: a review of methods and clinical applications.
M. Motwani (2013)
Cardiac MR imaging: current status and future direction.
M. Saeed (2015)
This paper is referenced by